HHLR ADVISORS, LTD.'s Net Worth
$22.8 Billion
Who is HHLR ADVISORS, LTD.?
HHLR ADVISORS, LTD. has an estimated net worth of $22.8 Billion. This is based on reported shares across multiple companies, which include ArriVent Biopharma, Inc., BeiGene, Ltd., and Cellular Biomedicine Group, Inc..
SEC CIK
HHLR ADVISORS, LTD.'s CIK is 0001762304
Past Insider Trading and Trends
2024 was HHLR ADVISORS, LTD.'s most active year for acquiring shares with 3 total transactions. HHLR ADVISORS, LTD.'s most active month to acquire stocks was the month of December. 2023 was HHLR ADVISORS, LTD.'s most active year for disposing of shares, totalling 8 transactions. HHLR ADVISORS, LTD.'s most active month to dispose stocks was the month of May. 2024 saw HHLR ADVISORS, LTD. paying a total of $9,999,990.00 for 4,484,672 shares, this is the most they've acquired in one year. In 2023 HHLR ADVISORS, LTD. cashed out on 4,154,817 shares for a total of $823,490,197.76, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ArriVent Biopharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.48M |
$18.00 |
—
| 4.48M |
Jan 30
| |||
| No matching records found | |||||||||
BeiGene, Ltd. (BGNE) Snapshot price: $153.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.83% | -1.20M |
$188.88 | -$226,306,339.45 | 142.89M |
Jun 13 - Jun 14
| |||
Form 4
| -2.01% | -2.96M |
$201.98 | -$597,183,858.31 | 144.09M |
Jun 8 - Jun 12
| |||
Form 4
| +0.01% | 7.8K |
—
|
—
| 147.04M |
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cellular Biomedicine Group, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||